Last Patient Last Visit for landmark Tourette Syndrome study
(Stockholm, 2 February 2023.) The Last Patient’s Last Visit took place on 1 February less than 12 months after the study’s initiation in Asarina Pharma’s… Read More »Last Patient Last Visit for landmark Tourette Syndrome study